Selecta Biosciences
SELB
Rank
4730
Country
USA
Exchange
NASDAQ
Currency
USD
Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Address
65 GROVE STREET, WATERTOWN, MA, US
Selecta Biosciences - Key figures
Market cap
360.4 Million
Revenue
127.64 Million
Profit
16.34 Million
P/E Ratio
23.6
P/s Ratio
2.824
Selecta Biosciences - Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, researches and develops nanoparticle immunomodulatory drugs for the treatment and prevention of human disease.
The company is headquartered in Watertown, Massachusetts.